We're #hiring a new Senior Project Manager in Lynnwood, Washington. Apply today or share this post with your network.
Partner Therapeutics
生物技术研究
Lexington，Massachusetts 4,420 位关注者
Partner Therapeutics is committed to improving the lives of patients with cancer and other serious illnesses.
关于我们
WE'RE ALL IN FOR FIGHT AGAINST CANCER Partner Therapeutics is devoted to developing and commercializing cancer medicines and combination therapies that can make a meaningful difference in the lives of cancer patients. We are united in our passion for improving the treatment of cancer and our desire to make a meaningful contribution to outcomes. THE PATIENT IS NUMBER ONE We believe that being a cancer company begins and ends with the patient. We strive to support patient needs throughout their treatment journey to help them make the treatment choices that are right for them and their loved ones. FIGHTING CANCER IS TEAM SPORT We believe that cancer is a complex, dynamic disease that requires a multi-faceted, multi-disciplinary approach to tackle. We believe in teamwork at each stage of a therapy’s development, and seek to build teams of experts, both internally and externally, that cover the breadth and depth of the complex problem that is cancer. We work with leading companies and investigators to ensure that our products are tested in the best settings, and in combination with highest potential regimens to maximize benefit to patients and to advance the understanding of cancer treatment. We seek to engage all members of the cancer treatment team as well as thought-leading physicians and patient advocacy organizations to ensure that clear, complete and balanced information about our products is proactively communicated and readily available. We work to support the extraordinary dedication of the medical teams that represent the front lines in the war on cancer. OUTCOMES ARE OUR YARDSTICK We believe that innovation is not enough. In the challenging world of today’s healthcare climate, we strive to develop and assess our products based on the real-world impact they have in improving the quality and duration of our patients’ lives. We measure our success in the birthdays, anniversaries and other important life moments that our patients are able to enjoy.
- 网站
-
https://www.partnertx.com
Partner Therapeutics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Lexington，Massachusetts
- 类型
- 私人持股
- 创立
- 2017
地点
Partner Therapeutics员工
动态
-
Looking forward to this precision oncology webinar this week!
Join us for an exciting Lab Talk on Precision Oncology! Date: 5th March Time: 12pm CT Discover cutting-edge insights in precision oncology with Dr. Pranil Chandra, Senior Vice President and Chief Genomics Officer at PathGroup, as he leads the latest Diaceutics Lab Talk, hosted by CAP TODAY: “Testing for NRG1 fusions: The new kid on the block of actionable pathogenic gene fusions”.? ? In this engaging session, Dr. Chandra will delve into:? ? - The role of pathogenic gene fusions as oncogenic drivers and actionable biomarkers? - A deep dive into NRG1 fusions, including their clinical utility as poor prognostic factors across tumor types? - The metastatic potential and unique histological features of NRG1+ tumors? - Practical guidance on testing for NRG1 fusions using targeted NGS approaches and RNA-based NGS techniques? ? Stay until the end for a live Q&A session, where you’ll have the chance to ask Dr. Chandra your questions and gain valuable insights. Don’t miss this opportunity to learn from one of the leading experts in genomics and oncology.?? ? Secure your spot today and stay at the forefront of advancements in cancer diagnostics and treatment!? ? Register now to reserve your seat! https://lnkd.in/dCZwRcS7 If you can’t make it to the live session, all registrants will be able to access the recording.?
-
Attending the IASLC 2025 Targeted Therapies of Lung Cancer Meeting #TTLC??Visit us at Booth 20. Did you know that pathogenic fusions are a contributing factor in 1 in 6 cancers1??Go to FindTheFusions.com. #PrecisionOncology #FindTheFusions #PrecisionMedicine
-
-
We're #hiring a new Executive Director, Quality Assurance in Lynnwood, Washington. Apply today or share this post with your network.
-
We're #hiring a new Executive Director, Quality Assurance in Lynnwood, Washington. Apply today or share this post with your network.
-
We're #hiring a new Protein Purification Scientist in Lynnwood, Washington. Apply today or share this post with your network.
-
We're #hiring a new Associate Scientist in Lynnwood, Washington. Apply today or share this post with your network.
-
We're #hiring a new Director of Regulatory Affairs in Lexington, Massachusetts. Apply today or share this post with your network.
-
Congratulations to the authors on their publication in the New England Journal of Medicine titled “Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer.” Many thanks to the patients and investigators who participated in the eNRGy clinical trial and to our partners at Merus N.V. Link to press release: https://bit.ly/4gsud5a
-
-
Attending the 2025 ASCO Gastrointestinal Cancers Symposium??Visit us at Booth 23.?Did you know that NRG1+ tumors may have a higher rate of metastasis compared with KRAS+ tumors? Go to FindTheFusions.com and find out more about the metastatic potential of NRG1+ tumors. #PrecisionOncology #FindTheFusions #PrecisionMedicine
-